Moreover, we stained CLL cells (n = 3) and normal B cells (n = 3) with anti-ET-1 antibody, revealing an increased amount of ET-1 peptide in CLL as compared to normal B lymphocytes (Figure 1B). This evidence concerns the gene EDN1 and B-cell chronic lymphocytic leukemia.